Observation of the efficacy of Danhong injection combined with irbesartan in treatment of early diabetic nephropathy
10.3760/cma.j.issn.1008-6706.2011.03.002
- VernacularTitle:丹红注射液联合厄贝沙坦治疗早期糖尿病肾病的疗效观察
- Author:
Ling DAI
;
Hui LIU
- Publication Type:Journal Article
- Keywords:
Diabetic nephropathy;
Danhong injection;
Irbesartan
- From:
Chinese Journal of Primary Medicine and Pharmacy
2011;18(3):291-292
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the effect of the Danhong injection combined with irbesartan in treatment ofearly diabetic nephropathy. Methods 64 patients with early diabetic nephropathy were randomly divided into two groups and the control group 32 cases,two groups were given control of blood sugar and ensure water and electrolyte balance,support therapy,in which 32 cases were also observed red Danhong injection,Ecuador irbesartan treatment,2weeks before evaluation. Results The total effective rate in treatment group was higher than the control group( x2 =6.38 ,P ＜0. 05) ,after 12 weeks of treatment,two groups of urinary protein decreased significantly compared with before treatment, including observation of urine protein was ( 0. 6± 0. 1 ) g/24h, the control group was ( 0. 7 ± 0. 3 ) g/24h,and decreased urine protein level of the observation group was better than the control group( t = 2. 74,P ＜ 0. 05 ). And in the course of treatment, side effects and serious adverse events were not found. Conclusion Danhong injection combined irbesartar, could improve the clinical symptoms, reduce microalbuminuria in treatment of early diabetic nephropathy is worthy of wider application.
